Improved adjuvanting of seasonal influenza vaccines: Pre-clinical studies of MVA-NP+M1 co-administration with inactivated influenza vaccine.

Mullarkey, Caitlin E, Boyd, Amy, van Laarhoven, Arjan, Lefevre, Eric A, Carr, B Veronica, Baratelli, Massimiliano, Molesti, Eleonora, Temperton, Nigel J., Butter, Colin, Charleston, Bryan, and others. (2013) Improved adjuvanting of seasonal influenza vaccines: Pre-clinical studies of MVA-NP+M1 co-administration with inactivated influenza vaccine. European Journal of Immunology, 43 (7). pp. 1940-1952. ISSN 0014-2980. (doi:10.1002/eji.201242922)

PDF - Author's Accepted Manuscript
Download (440kB) Preview
[img]
Preview
Official URL
http://dx.doi.org/10.1002/eji.201242922

Abstract

Licensed seasonal influenza vaccines induce antibody responses against influenza hemagglutinin that are limited in their ability to protect against different strains of influenza. Cytotoxic T lymphocytes (CTLs) recognizing the conserved internal nucleoprotein (NP) and matrix protein (M1) are capable of mediating a cross-subtype immune response against influenza. Modified vaccinia virus Ankara encoding NP and M1 (MVA-NP+M1) is designed to boost pre-existing T-cell responses in adults in order to elicit a cross-protective immune response. We examined the co-administration of hemagglutinin (HA) protein formulations and candidate MVA-NP+M1 influenza vaccines in murine, avian, and swine models. Antibody responses post-immunization were measured by ELISA and pseudotype neutralization assays. Here we demonstrate that MVA-NP+M1 can act as an adjuvant enhancing antibody (Ab) responses to HA while simultaneously inducing potent T-cell responses to conserved internal antigens. We show that this regimen leads to the induction of cytophilic Ab isotypes that are capable of inhibiting hemagglutination and in the context of H5 exhibit cross-clade neutralization. The simultaneous induction of T cells and antibody responses has the potential to improve seasonal vaccine performance and could be employed in pandemic situations.

Item Type: Article
DOI/Identification number: 10.1002/eji.201242922
Subjects: Q Science > QR Microbiology > QR355 Virology
Divisions: Faculties > Sciences > Medway School of Pharmacy
Depositing User: Nigel Temperton
Date Deposited: 19 Apr 2013 12:32 UTC
Last Modified: 29 May 2019 10:07 UTC
Resource URI: https://kar.kent.ac.uk/id/eprint/33647 (The current URI for this page, for reference purposes)
  • Depositors only (login required):

Downloads

Downloads per month over past year